Migration of Pseudomonas aeruginosa towards antibiotics: mechanisms and consequences.
- Funding
- Self-funded
- Study mode
- Full-time
- Part-time
- Apply by
- Start date
- Year round
- Subject area
- Biological and Biomedical Sciences
P.aeruginosa is a globally significant “priority” bacterial pathogen (WHO) that causes life-threatening antibiotic-resistant infections. Whilst P.aeruginosa is widely studied in liquid-culture, most cells in natural and clinical settings live within surface-attached biofilms. Whilst liquid-borne bacteria swim away from harmful chemicals, we recently found that surface-attached P.aeruginosa counter-intuitively crawls towards – rather than away from – clinical antibiotics, a novel behaviour we call ‘antibiotic taxis’[1,2]. This exciting discovery raises many new questions about the genetic and behavioural mechanisms underlying this response and whether it allows cells to acquire resistance.
Background:
P.aeruginosa is a globally significant “priority” bacterial pathogen (WHO) that causes life-threatening antibiotic-resistant infections. Whilst P.aeruginosa is widely studied in liquid-culture, most cells in natural and clinical settings live within surface-attached biofilms. Whilst liquid-borne bacteria swim away from harmful chemicals, we recently found that surface-attached P.aeruginosa counter-intuitively crawls towards – rather than away from – clinical antibiotics, a novel behaviour we call ‘antibiotic taxis’[1,2]. This exciting discovery raises many new questions about the genetic and behavioural mechanisms underlying this response and whether it allows cells to acquire resistance.
We speculate that antibiotic taxis enables P.aeruginosa to respond to antibiotics produced by competing bacteria by navigating directly towards them in a counterattack manoeuvre. For example, surface-attached P.aeruginosa has been found to migrate towards toxins produced by Staphylococcus aureus, a species with which it commonly co-infects cystic fibrosis patients[3]. However, the mechanistic basis of this response, and how it facilitates competitive interactions between co-infecting pathogens, remains unknown. In addition, little is known about the implications of antibiotic taxis in the context of clinical antibiotics and how it contributes to the prevalence of antibiotic resistance in P.aeruginosa. This project will begin to address these questions, developing a fundamentally new understanding of how bacteria interact with both synthetic clinical antibiotics and anti-microbials produced by competing strains during co-infection, potentially shedding new light on how bacteria acquire antibiotic resistance.
Objective 1:
How does antibiotic taxis facilitate resistance evolution? We have previously studied antibiotic taxis using steep gradients that drive strong responses, but these ultimately kill responding cells. Here, we will use microfluidics to generate realistic antibiotic landscapes to resolve how movement towards progressively higher antibiotic concentrations might facilitate resistance evolution over multiple days.
Objective 2:
How do cells sense antibiotic gradients? We found that the Pil-Chp signalling pathway regulates chemotaxis in surface-attached P.aeruginosa[4,5]. However, the receptor associated with this pathway is not required for antibiotic taxis, implicating a novel sensing mechanism. We will resolve the molecular components underpinning antibiotic taxis using mutants and sophisticated cell-tracking tools to analyse their behaviour.
Objective 3:
What attracts P.aeruginosa towards S.aureus colonies? Bacteria secrete diverse compounds that could impact motility. Using microfluidic assays, we will identify compounds driving P.aeruginosa attraction to S.aureus colonies (including recently implicated toxins) and resolve the behavioural/genetic mechanisms involved.
Research approach:
These objectives require an inherently interdisciplinary and collaborative approach: our supervisors (Dr Jamie Wheeler (University of Liverpool), Dr William Durham, (https://microbialphysicsgroup.sites.sheffield.ac.uk/people) and Prof. Aras Kadioglu (https://www.liverpool.ac.uk/people/aras-kadioglu)) combine expertise across molecular microbiology, microfluidics, automated-microscopy, massively parallel cell-tracking and immunology. The successful student will receive extensive training across these disciplines, working with state-of-the-art tools. For instance, our supervisory team has been directly involved in the development of novel technologies (including 3D-printed fluid-walled microfluidic devices[2,6] and custom cell-tracking software[7]) that have opened new ways of studying bacteria.
Together, we adopt a strongly collaborative and inclusive research approach fostering creativity, cooperation and student-led networking opportunities. The successful student will therefore be well equipped for a future career in cutting-edge research, using diverse tools to answer fundamental problems in biology.
(https://www.nature.com/articles/s41467-022-35311-4)
(https://pubs.acs.org/doi/10.1021/acsami.2c07177)
(https://elifesciences.org/articles/47365)
(https://www.pnas.org/doi/10.1073/pnas.1600760113)
(https://www.nature.com/articles/s41564-024-01729-3#:~:text=These%20experiments%20revealed%20that%20P,sense%20chemical%20gradients%20in%20space.)
(https://www.nature.com/articles/s41467-017-00846-4)
(https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1011524)
This project is open to UK and international applicants with their own funding. Funding should cover course fees, living expenses and research expenses (bench fees).
Please email your CV, cover letter and the project title to the primary supervisor, Dr Jamie Wheeler, in the first instance j.h.wheeler@liverpool.ac.uk
You may need the following documents to complete your online application:
Finally, register and apply online. You'll receive an email acknowledgment once you've submitted your application. We'll be in touch with further details about what happens next.
Your tuition fees, funding your studies, and other costs to consider.
Full-time place, per year - £5,006
Part-time place, per year - £2,503
Full-time place, per year - £31,250
Part-time place, per year - £15,650
Fees stated are for 2025/26 academic year
We understand that budgeting for your time at university is important, and we want to make sure you understand any costs that are not covered by your tuition fee. This could include buying a laptop, books, or stationery.
Find out more about the additional study costs that may apply to this project, as well as general student living costs.
If you're a UK national, or have settled status in the UK, you may be eligible to apply for a Postgraduate Doctoral Loan worth up to £30,301 to help with course fees and living costs.
There’s also a variety of alternative sources of funding. These include funded research opportunities and financial support from UK research councils, charities and trusts. Your supervisor may be able to help you secure funding.
We've set the country or region your qualifications are from as United Kingdom.
We offer a range of scholarships and bursaries that could help pay your tuition fees and living expenses.
If you’re awarded this prestigious scholarship, you’ll receive significant funding to support your postgraduate research. This includes full payment of your PhD fees and a cash bursary of £17,000 per year while you study. One award is available in each academic year.
If you’re a UK student, either born in or with strong family connections to Merseyside, you could be eligible to apply for financial support worth up to £12,000 per year for up to three years of full-time postgraduate research (or up to five years part-time pro-rata).
Apply to receive tailored training support to enhance your sporting performance. Our athlete support package includes a range of benefits, from bespoke strength and conditioning training to physiotherapy sessions and one-to-one nutritional advice.
Have a question about this research opportunity or studying a PhD with us? Please get in touch with us, using the contact details below, and we’ll be happy to assist you.